Johns Hopkins investigators develop novel treatment for T-cell leukemias and lymphomas

(Newswise) — A novel treatment for leukemias and lymphomas that arise from immune system T cells, developed by investigators at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center and Lustgarten Laboratory, was found to be effective at killing these cancers in mice bearing human T-cell tumors. The therapy, an antibody-drug conjugate (ADC), combines […] The post Johns Hopkins investigators develop novel treatment for T-cell leukemias and lymphomas appeared first on North Dallas Gazette.